In the last few years, we’ve seen a few sleeker-looking glucose meters make it to market, along with more logging tools and apps than we can shake a stick at. But what’s still been lacking is some good assistance in taking all those numbers and actually knowing what to do with them — what changes do they call for in our diabetes management?
Unless you’re telephoning your CDE or endo every time you spot some…
“If this book were a video game it would be rated ‘Mature’ for a sprinkling of explicit language and for deadly serious subject matter.”
— statement kicking off the “Preface” of Wil Dubois’ latest book, Beyond Fingersticks
Whoa.
While I might have to disagree with Wil’s idea of “sprinkling” (I lost count of how many choice four letter words there were in this pint-sized, yet heavy-duty instruction manual), I completely agree that discussing CGM use…
Read more »
Insulin maker Sanofi-Aventis took a big hit last year with the Lantus-cancer scare. But that hasn’t stopped them from charging ahead in diabetes care. According to industry observers, the company’s new US Diabetes unit, fueled by a recent “acquisition binge,” is gearing up to “turn the diabetes world upside-down” with a full set of new offerings to help doctors help patients achieve better outcomes. Sounds intriguing!
I caught up last week with Dennis Urbaniak, Sanofi’s…